Cargando…

The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1

Soluble fms-like tyrosine kinase-1 (sFlt-1) is a secreted protein that binds heparan sulfate expressed on the endothelial glycocalyx (eGC). In this paper we analyze how excess sFlt-1 causes conformational changes in the eGC, leading to monocyte adhesion, a key event triggering vascular dysfunction....

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Annika, Drost, Carolin C., Hesse, Bettina, Beul, Katrin, Boeckel, Göran R., Lukasz, Alexander, Pavenstädt, Hermann, Brand, Marcus, Di Marco, Giovana S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049398/
https://www.ncbi.nlm.nih.gov/pubmed/36982455
http://dx.doi.org/10.3390/ijms24065380
_version_ 1785014449489313792
author Schulz, Annika
Drost, Carolin C.
Hesse, Bettina
Beul, Katrin
Boeckel, Göran R.
Lukasz, Alexander
Pavenstädt, Hermann
Brand, Marcus
Di Marco, Giovana S.
author_facet Schulz, Annika
Drost, Carolin C.
Hesse, Bettina
Beul, Katrin
Boeckel, Göran R.
Lukasz, Alexander
Pavenstädt, Hermann
Brand, Marcus
Di Marco, Giovana S.
author_sort Schulz, Annika
collection PubMed
description Soluble fms-like tyrosine kinase-1 (sFlt-1) is a secreted protein that binds heparan sulfate expressed on the endothelial glycocalyx (eGC). In this paper we analyze how excess sFlt-1 causes conformational changes in the eGC, leading to monocyte adhesion, a key event triggering vascular dysfunction. In vitro exposure of primary human umbilical vein endothelial cells to excess sFlt-1 decreased eGC height and increased stiffness as determined by atomic force microscopy (AFM). Yet, structural loss of the eGC components was not observed, as indicated by Ulex europaeus agglutinin I and wheat germ agglutinin staining. Moreover, the conformation observed under excess sFlt-1, a collapsed eGC, is flat and stiff with unchanged coverage and sustained content. Functionally, this conformation increased the endothelial adhesiveness to THP-1 monocytes by about 35%. Heparin blocked all these effects, but the vascular endothelial growth factor did not. In vivo administration of sFlt-1 in mice also resulted in the collapse of the eGC in isolated aorta analyzed ex vivo by AFM. Our findings show that excess sFlt-1 causes the collapse of the eGC and favors leukocyte adhesion. This study provides an additional mechanism of action by which sFlt-1 may cause endothelial dysfunction and injury.
format Online
Article
Text
id pubmed-10049398
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100493982023-03-29 The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1 Schulz, Annika Drost, Carolin C. Hesse, Bettina Beul, Katrin Boeckel, Göran R. Lukasz, Alexander Pavenstädt, Hermann Brand, Marcus Di Marco, Giovana S. Int J Mol Sci Article Soluble fms-like tyrosine kinase-1 (sFlt-1) is a secreted protein that binds heparan sulfate expressed on the endothelial glycocalyx (eGC). In this paper we analyze how excess sFlt-1 causes conformational changes in the eGC, leading to monocyte adhesion, a key event triggering vascular dysfunction. In vitro exposure of primary human umbilical vein endothelial cells to excess sFlt-1 decreased eGC height and increased stiffness as determined by atomic force microscopy (AFM). Yet, structural loss of the eGC components was not observed, as indicated by Ulex europaeus agglutinin I and wheat germ agglutinin staining. Moreover, the conformation observed under excess sFlt-1, a collapsed eGC, is flat and stiff with unchanged coverage and sustained content. Functionally, this conformation increased the endothelial adhesiveness to THP-1 monocytes by about 35%. Heparin blocked all these effects, but the vascular endothelial growth factor did not. In vivo administration of sFlt-1 in mice also resulted in the collapse of the eGC in isolated aorta analyzed ex vivo by AFM. Our findings show that excess sFlt-1 causes the collapse of the eGC and favors leukocyte adhesion. This study provides an additional mechanism of action by which sFlt-1 may cause endothelial dysfunction and injury. MDPI 2023-03-11 /pmc/articles/PMC10049398/ /pubmed/36982455 http://dx.doi.org/10.3390/ijms24065380 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schulz, Annika
Drost, Carolin C.
Hesse, Bettina
Beul, Katrin
Boeckel, Göran R.
Lukasz, Alexander
Pavenstädt, Hermann
Brand, Marcus
Di Marco, Giovana S.
The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1
title The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1
title_full The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1
title_fullStr The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1
title_full_unstemmed The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1
title_short The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1
title_sort endothelial glycocalyx as a target of excess soluble fms-like tyrosine kinase-1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049398/
https://www.ncbi.nlm.nih.gov/pubmed/36982455
http://dx.doi.org/10.3390/ijms24065380
work_keys_str_mv AT schulzannika theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT drostcarolinc theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT hessebettina theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT beulkatrin theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT boeckelgoranr theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT lukaszalexander theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT pavenstadthermann theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT brandmarcus theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT dimarcogiovanas theendothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT schulzannika endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT drostcarolinc endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT hessebettina endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT beulkatrin endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT boeckelgoranr endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT lukaszalexander endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT pavenstadthermann endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT brandmarcus endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1
AT dimarcogiovanas endothelialglycocalyxasatargetofexcesssolublefmsliketyrosinekinase1